APAC Chronic Cough Market, Market Segmented, by Drug Class (Antihistamines, Corticosteroids, Decongestants, Combination Drug, Antibiotics, Acid Blockers, and Other Drug Class), by Route of Administration (Oral, Injections, Nasal, Other Route of Administration), and by Distribution Channel (Hospital Pharmacy, Online Pharmacy, and Retail Pharmacy)- Growth, Trends and Forecast, 2019-2028
- Published Date: 2022-12-26
- Report ID: 138301
- Pages: 200
-
Format:
Report Overview
The APAC Chronic Cough Market, market size stood at around USD $0.02 billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period
Typically defined as acoughthat persists for longer than 8 weeks, this is the most common presenting symptom in adults who seek medical treatment in an ambulatory setting.Chronic coughis estimated to occur in up to 40% of the population
Market Drivers
The rising incidences of chronic cough, growing product developments to treat chronic cough are some of the primary factors contributing to the dominance of the segment in the Asia Pacific chronic cough market Furthermore,aging population is expected to drive demand for chronic cough treatmentis likely to offer significant opportunities for the growth of the Asia Pacific chronic cough market
1. APAC Chronic Cough Market Overview
A. Market Size
2. APAC Chronic Cough Market Growth Drivers and Restraints
A. The rising incidences of chronic cough, growing product developments to treat chronic cough
B. Aging population
3. APAC Chronic Cough Market Segmentation
A. By Drug Class
I. Antihistamines
II. Corticosteroids
III. Decongestants
IV. Combination Drug
V. Antibiotics
VI. Acid Blockers
VII. Other Drug Class
B. By Route of Administration
I. Oral
II. Injections
III. Nasal
IV. Other Route of Administration
C. By Distribution Channel
I. Hospital Pharmacy
II. Online Pharmacy
III. Retail Pharmacy
4. APAC Chronic Cough Market Share
A. Market Analysis, Insights and Forecast by Revenue
5. Competitive Landscape
A. Major Players
B. Products in Pipeline
6. Key Company Profiles..
A. GlaxoSmithKline plc, Company overview, Product & Services, Strategies & Financials
B. Bayer AG, Company overview, Product & Services, Strategies & Financials
C. Mylan N.V., Company overview, Product & Services, Strategies & Financials
7. Healthcare Policies and Regulatory Landscape.
A. Policy Changes and Reimbursement Scenario
8. Factors Driving Market Growth
A. Key Industry Developments
B. Mergers and Acquisitions
9. Potential Growth Opportunities
A. Market Opportunities
B. Future Trends
10. Conclusion
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
